Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir, Peginterferon, and Ribavirin in HCV Genotype 1 and ESRD
NCT01731301Phase 4Unknown
- Sponsor
- Liver Institute of Virginia
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of boceprevir in hepatitis C virus infection, sponsored by Liver Institute of Virginia. Status: unknown.
02
Drugs
boceprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01731301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731301.